Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

BackgroundPatients with extreme body mass indices (BMI) could have an increased risk of death while hospitalized for COVID-19.MethodsThe database of the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) was used to assess the time to in-hospital death with competing-risks regression by sex and between the categories of BMI.ResultsData from 12,137 patients (age 60.0 ± 16.2 years, 59% males, BMI 29.4 ± 6.9 kg/m2) of 48 countries were available. By univariate analysis, underweight patients had a higher risk of mortality than the other patients (sub-hazard ratio (SHR) 1.75 [1.44-2.14]). Mortality was lower in normal (SHR 0.69 [0.58-0.85]), overweight (SHR 0.53 [0.43-0.65]) and obese (SHR 0.55 [0.44-0.67]) than in underweight patients. Multivariable analysis (adjusted for age, chronic pulmonary disease, malignant neoplasia, type 2 diabetes) confirmed that in-hospital mortality of underweight patients was higher than overweight patients (females: SHR 0.63 [0.45-0.88] and males: 0.69 [0.51-0.94]).ConclusionEven though these findings do not imply changes in the medical care of hospitalized patients, they support the use of BMI category for the stratification of patients enrolled in interventional studies where mortality is recorded as an outcome.

Original publication

DOI

10.1016/j.clnu.2022.01.017

Type

Journal

Clinical nutrition (Edinburgh, Scotland)

Publication Date

12/2022

Volume

41

Pages

2924 - 2926

Addresses

Department of Biomedical Research, Université Libre de Bruxelles, B-1070, Brussels, Belgium.

Keywords

ISARIC Clinical Characterisation Group, Humans, Diabetes Mellitus, Type 2, Thinness, Body Mass Index, Hospital Mortality, Risk Factors, Adult, Aged, Middle Aged, Female, Male, Overweight, COVID-19